Literature DB >> 1949215

Association of pulmonary tuberculosis and HLA in south India.

V Brahmajothi1, R M Pitchappan, V N Kakkanaiah, M Sashidhar, K Rajaram, S Ramu, K Palanimurugan, C N Paramasivan, R Prabhakar.   

Abstract

In 204 patients with smear-positive pulmonary tuberculosis HLA-A10, B8 and DR2 were more frequently found than in 404 control subjects (p = 0.01); the greatest attributable risk (0.29) was associated with HLA-DR2. The radiographic extent of disease was also associated with HLA-DR2 (p = 0.0001). In 152 patients with smear-negative pulmonary tuberculosis, the frequencies of HLA-A10 and B8, but not DR2, were greater in the control subjects (p = 0.001 and 0.01 respectively). HLA-DR2 may be involved in the pathogenesis of advanced pulmonary tuberculosis. Study of endogamous, genetically disparate populations (caste) revealed other HLA associations (A3, B12 and DR4) unique to them, suggesting that genes linked with the HLA complex might also be significant in the pathogenesis of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949215     DOI: 10.1016/0041-3879(91)90039-u

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  19 in total

1.  HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance.

Authors:  A G White; J Bogh; W Leheny; P Kuchipudi; M Varghese; H al Riyami; S al Hashmi; A S Daar
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  Mycobacterium bovis BCG scar status and HLA class II alleles influence purified protein derivative-specific T-cell receptor V beta expression in pulmonary tuberculosis patients from southern India.

Authors:  S Shanmugalakshmi; V Dheenadhayalan; P Muthuveeralakshmi; G Arivarignan; R M Pitchappan
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 3.  HLA and disease.

Authors:  Yogita Ghodke; Kalpana Joshi; Arvind Chopra; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 4.  Genetics and pulmonary medicine. 3. Genetic susceptibility to tuberculosis in human populations.

Authors:  R Bellamy
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 5.  Polymorphisms in HLA-DRB1 gene and the risk of tuberculosis: a meta-analysis of 31 studies.

Authors:  Xiang Tong; Lingmin Chen; Sitong Liu; Zhipeng Yan; Shifeng Peng; Yonggang Zhang; Hong Fan
Journal:  Lung       Date:  2015-02-18       Impact factor: 2.584

Review 6.  Knowledge gaining by human genetic studies on tuberculosis susceptibility.

Authors:  Hui-Qi Qu; Susan P Fisher-Hoch; Joseph B McCormick
Journal:  J Hum Genet       Date:  2010-12-23       Impact factor: 3.172

7.  Allelic distribution of human leucocyte antigen in historical and recently diagnosed tuberculosis patients in Southern Italy.

Authors:  Giuseppina Ruggiero; Elena Cosentini; Delia Zanzi; Veronica Sanna; Giuseppe Terrazzano; Giuseppe Matarese; Alessandro Sanduzzi; Francesco Perna; Serafino Zappacosta
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

8.  Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis.

Authors:  Graham S Cooke; Sarah J Campbell; Steve Bennett; Christian Lienhardt; Keith P W J McAdam; Giorgio Sirugo; Oumou Sow; Per Gustafson; Frank Mwangulu; Paul van Helden; Paul Fine; Eileen G Hoal; Adrian V S Hill
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

9.  Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice.

Authors:  Fabio Sánchez; Tatiana V Radaeva; Boris V Nikonenko; Ann-Sophie Persson; Selim Sengul; Martin Schalling; Erwin Schurr; Alexander S Apt; Catharina Lavebratt
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Heritability analysis of cytokines as intermediate phenotypes of tuberculosis.

Authors:  Catherine M Stein; David Guwatudde; Margaret Nakakeeto; Pierre Peters; Robert C Elston; Hemant K Tiwari; Roy Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2003-05-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.